The global market for scleral lenses is expected to enjoy a valuation of USD 175.5 million in the year 2022, and further expand at a CAGR of 6.3% to reach a valuation of ~USD 323.5 million by the year 2032. According to a recent study by Future Market Insights, the mini scleral lenses in the product segment are leading the market with a share of about 47.4% in the year 2021, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 175.5 million |
| Market Value 2032 | USD 323.5 million |
| CAGR 2022 to 2032 | 6.3% |
| Market Share of Top 5 Countries | 73.3% |
| Key Market Players | Cooper Vision; (VisionaryOptic) Euclid Systems; Bausch & Lomb; Art Optical Contact Lens; Inc.; AccuLens; Valley Contax Inc.; ABB Optical Group; EssilorLuxottica; Optact International Ltd.; Solotica; Smart Optics LLC; OPTO CENTAR; OKVision; No7 Contact Lenses; Multilens AB; Laboratoire LCS; HERZ submicron lathing s.r.l.; Gelflex; Firma Concor Ltd.; Biolens Lab; Appenzeller Kontaktlinsen AG; Advanced Vision Technologies; and Metro Optics |
Scleral lenses are large-diameter lenses that have been specifically designed to completely cover the sclera and corneal surface.
Scleral lenses are more stable on the eyes than other conventional lenses because of their size. These lenses are highly breathable and are made of stiff permeable lens materials wherein the surface of the eyes receives plenty of oxygen because of the high-quality material properties of these lenses.
Scleral lenses are used for conditions like corneal irregularity, surface ocular disease, and refractive error. It is used to treat a variety of diseases, including keratoconus, microphthalmia, neurotrophic keratitis, dry eye syndrome, pellucid marginal degeneration, corneal scarring, and other ailments.
Manufacturers offer scleral lenses that are specifically sized and diseased to meet the needs of patients. Scleral lenses are becoming a popular treatment option for older people and youngsters. People whose eyes are too sensitive for smaller contact lenses are increasingly turning to scleral lenses.
Thus owing to such importance and advancement in the product portfolio, the global scleral lenses market is expected to see growth in the forecast period.
The market value of the scleral lenses was approximately 1.4% of the overall ~USD 11.8 billion global contact lens market in 2021.
The sales of scleral lens products expanded at a CAGR of 3.0% from 2012 to 2021.
Over the projection period, it is anticipated that there will be a strong demand for scleral lenses because of the rising incidence of eye illnesses and difficulties. The market for scleral lenses is anticipated to develop as a result of the rising demand for eye movement analysis. The market is also anticipated to develop because of the increasing older population, a rise in the number of people seeking treatment, and changes in lifestyle.
The market for scleral lenses is anticipated to expand as a result of rising demand for non-surgical products for vision care and treatment. One of the major trends in the scleral lenses industry is the rise in customized scleral lens production. The market is anticipated to rise as scleral lenses are increasingly prescribed to treat corneal irregularities and ocular surface diseases.
As per an article published in 2017 by the contact lens spectrum, the SCOPE (Scleral Lenses in Current Ophthalmic Practice Evaluation) study group, in n=673, it was observed that the most frequent reason for using scleral lenses was reported to be corneal irregularity, 74%, followed by ocular surface illness, 16%, and refractive error, 10%.
Thus, owing to the aforementioned factors, the global market for scleral lenses is expected to grow at a CAGR of 6.3% during the forecast period from 2022 to 2032.
Considering the growing awareness in developing countries, the market is expected to have a positive outlook. The adoption rate is increasing with new products entering the emerging market. This growth is attributed to the developing nations' increasing collaboration and effort of the manufacturers.
For instance, The LV Prasad Eye Institute (LVPEI) and Boston Foundation collaborated in 2017 to improve access to specialized lenses for patients in developing geographies. There is now Boston Sight SCLERAL & PROSE in India and they are starting to cater to patients in other countries of South and Middle-East Asia as well.
The market is having an opportunistic outlook as the patient currently looks for advanced products that would ease their day-to-day activities along with providing comfort. This in turn benefits the manufacturers who are involved in providing new and customized products as per the need of the patients.
Thus, this can be considered an opportunistic factor for the growth and wider adoption of scleral lenses.
The major factor restraining the demand for scleral lenses is the high cost of the scleral lenses. These lenses are four to five times more expensive compared to other soft contact lenses or other standard contact lenses. The cost of the customized scleral lenses can be more than USD 4000 as well.
This in turn significantly decreases the adoption of scleral lenses for low and middle-income group patients. There are also minimal options for reimbursement of scleral lenses and most insurance companies do not directly cover the full cost of these lenses and thus can be a restraining factor in this aspect. Thus, it is a major growth concern, especially in some developing countries.
Other than this, certain side effects of the use of scleral lenses also have a negative impact on market growth. As per a retrospective study of keratoconus subjects examined between 2013 and 2018, conducted by the Southern College of Optometry, the complications of scleral lenses included 90.8% poor lens wetting, 84.8% lens fogging, 53% blurred vision, 34.8% ocular redness, 24.4% ocular dryness and 20.7% ocular pain and discomfort.
Thus, these abovementioned factors restrain the developmental growth of the scleral lenses market.
The USA dominates the North American region with total market revenue of about USD 69.09 million, and a similar trend is expected over the forecast period.
Due to the strong demand for scleral lenses as a treatment choice for various eye disorders in the USA, the country dominates the North American market for scleral lenses. The increasing number of eye disorders in The USA is adding to the wider adoption of scleral lenses. For instance, as per the Cornea Research Foundation of America, approximately 50 to 200 of every 100,000 people are afflicted with keratoconus.
Hence, the sales of scleral lenses in the USA are quite high and are anticipated to grow moving forward.
In 2021, Germany held a market share of about 44.7% in the Europe market.
Technical developments and growth in the usage of non-surgical eye care products are driving the industry forward. The development of a protective aqueous vault over the cornea, computer-assisted lens designs, computerized measurements of the topography of the ocular surface, and high-tech lens material qualities are a few examples of technical developments. Because of these technological developments, scleral lenses are now more widely used in Germany.
Thus, considering this factor, the market for scleral lenses in Germany is quite lucrative.
India held approximately 59.8% market share in South Asia in 2021.
In terms of scleral lenses, India is expected to see faster growth rates because of the advancements in medical technology, government support for the treatment of eye problems, and a large patient base. The increasing population in India and the increasing number of eye diseases will eventually increase the adoption of scleral lenses in the region.
Thus, it has eventually boosted the availability of scleral lens products in India and is expected to show optimum growth in the forecast period.
Mini scleral lenses are expected to present high growth at a CAGR of 4.9% by the end of the forecast period, with a contributing value of nearly USD 79.2 million in the global market in 2021. Mini-scleral lenses are firm lenses with a large diameter that are used to restore vision when the cornea is deformed due to disease, scarring, or following a corneal graft operation.
It is safe as well as well tolerated by many patients. The use of these lenses improves the quality of life. This is why the usage of mini scleral lenses is highest in the scleral lenses market.
Corneal irregularity is the most common indication and accounted for the largest revenue share globally valued at USD 82.2 million in 2021. Corneal irregularities such as keratoconus and pellucid marginal degeneration are quite common.
These instances are mostly known to be caused by genetic and environmental factors as well as collagen abnormalities. Corneal irregularity causes symptoms like distorted and blurry vision, sudden onset vision, or eye pain. The market is growing with the increase in cases of corneal irregularity.
The leading companies engage in a variety of product launches, expansions, collaborations, mergers, and acquisitions to enhance their global presence and improve their business strategy.
The primary advertising tactics used by the major participants in the scleral lenses market are listed below:
Similarly, recent developments related to companies manufacturing scleral lenses, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | USD million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | The USA Canada, Mexico, Brazil, Argentina, The United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, Turkey, South Africa, and North Africa |
| Key Market Segments Covered | Product, Indication, and Region |
| Key Companies Profiled | Cooper Vision; (VisionaryOptic) Euclid Systems; Bausch & Lomb; Art Optical Contact Lens, Inc.; AccuLens; Valley Contax Inc.; ABB Optical Group; EssilorLuxottica; Optact International Ltd.; Solotica, Smart Optics LLC; OPTO CENTER; OKVision; No7 Contact Lenses; Multilens AB; Laboratoire LCS; HERZ submicron lathing s.r.l.; Gelflex; Firma Concor Ltd.; Biolens Lab; Appenzeller Kontaktlinsen AG; Advanced Vision Technologies; Metro Optics |
| Pricing | Available upon Request |
Table 01: Global Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 03: Global Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 04: Global Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Region
Table 05: North America Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 06: North America Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 07: North America Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 08: North America Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 09: Latin America Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 10: Latin America Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 11: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 12: Latin America Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 13: Europe Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 14: Europe Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 15: Europe Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 16: Europe Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 17: South Asia Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 18: South Asia Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 19: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 20: South Asia Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 21: East Asia Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 22: East Asia Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 23: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 24: East Asia Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 25: Oceania Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 26: Oceania Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 27: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 28: Oceania Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Table 29: MEA Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 30: MEA Market Value (US$ million) Analysis and Forecast 2012 to 2032, By Product
Table 31: MEA Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product
Table 32: MEA Market Value (US$ million) Analysis and Forecast 2012 to 2032, by Indication
Figure 01: Global Market Volume (Units), 2012 to 2021
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022 to 2032
Figure 03: Scleral Lenses, Pricing Analysis per unit (US$), in 2021
Figure 04: Scleral Lenses, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value (US$ million) Analysis, 2012 to 2021
Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 07: Global Market Absolute $ Opportunity (US$ million) Analysis, 2021 to 2032
Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, By Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, By Product
Figure 10: Global Market Attractiveness Analysis 2022 to 2032, By Product
Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Indication
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Indication
Figure 13: Global Market Attractiveness Analysis 2022 to 2032, by Indication
Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region
Figure 16: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 17: North America Market Value (US$ million) Analysis, 2012 to 2021
Figure 18: North America Market Value (US$ million) Forecast, 2022 to 2032
Figure 19: North America Market Value Share, By Product (2022 E)
Figure 20: North America Market Value Share, by Indication (2022 E)
Figure 21: North America Market Value Share, by Country (2022 E)
Figure 22: North America Market Attractiveness Analysis By Product, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 25: The USA Market Value Proportion Analysis, 2021
Figure 26: Global Vs. The USA Growth Comparison
Figure 27: The USA Market Share Analysis (%) By Product, 2021 to 2032
Figure 28: The USA Market Share Analysis (%) by Indication, 2021 to 2032
Figure 29: Canada Market Value Proportion Analysis, 2021
Figure 30: Global Vs. Canada. Growth Comparison
Figure 31: Canada Market Share Analysis (%) By Product, 2021 to 2032
Figure 32: Canada Market Share Analysis (%) by Indication, 2021 to 2032
Figure 33: Latin America Market Value (US$ million) Analysis, 2012 to 2021
Figure 34: Latin America Market Value (US$ million) Forecast, 2022 to 2032
Figure 35: Latin America Market Value Share, By Product (2022 E)
Figure 36: Latin America Market Value Share, by Indication (2022 E)
Figure 37: Latin America Market Value Share, by Country (2022 E)
Figure 38: Latin America Market Attractiveness Analysis By Product, 2022 to 2032
Figure 39: Latin America Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 40: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 41: Mexico Market Value Proportion Analysis, 2021
Figure 42: Global Vs Mexico Growth Comparison
Figure 43: Mexico Market Share Analysis (%) By Product, 2021 to 2032
Figure 44: Mexico Market Share Analysis (%) by Indication, 2021 to 2032
Figure 45: Brazil Market Value Proportion Analysis, 2021
Figure 46: Global Vs. Brazil. Growth Comparison
Figure 47: Brazil Market Share Analysis (%) By Product, 2021 to 2032
Figure 48: Brazil Market Share Analysis (%) by Indication, 2021 to 2032
Figure 49: Argentina Market Value Proportion Analysis, 2021
Figure 50: Global Vs Argentina Growth Comparison
Figure 51: Argentina Market Share Analysis (%) By Product, 2021 to 2032
Figure 52: Argentina Market Share Analysis (%) by Indication, 2021 to 2032
Figure 53: Europe Market Value (US$ million) Analysis, 2012 to 2021
Figure 54: Europe Market Value (US$ million) Forecast, 2022 to 2032
Figure 55: Europe Market Value Share, By Product (2022 E)
Figure 56: Europe Market Value Share, by Indication (2022 E)
Figure 57: Europe Market Value Share, by Country (2022 E)
Figure 58: Europe Market Attractiveness Analysis By Product, 2022 to 2032
Figure 59: Europe Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 60: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 61: The United Kingdom Market Value Proportion Analysis, 2021
Figure 62: Global Vs. The United Kingdom Growth Comparison
Figure 63: The United Kingdom Market Share Analysis (%) By Product, 2021 to 2032
Figure 64: The United Kingdom Market Share Analysis (%) by Indication, 2021 to 2032
Figure 65: Germany Market Value Proportion Analysis, 2021
Figure 66: Global Vs. Germany Growth Comparison
Figure 67: Germany Market Share Analysis (%) By Product, 2021 to 2032
Figure 68: Germany Market Share Analysis (%) by Indication, 2021 to 2032
Figure 69: Italy Market Value Proportion Analysis, 2021
Figure 70: Global Vs. Italy Growth Comparison
Figure 71: Italy Market Share Analysis (%) By Product, 2021 to 2032
Figure 72: Italy Market Share Analysis (%) by Indication, 2021 to 2032
Figure 73: France Market Value Proportion Analysis, 2021
Figure 74: Global Vs France Growth Comparison
Figure 75: France Market Share Analysis (%) By Product, 2021 to 2032
Figure 76: France Market Share Analysis (%) by Indication, 2021 to 2032
Figure 77: Spain Market Value Proportion Analysis, 2021
Figure 78: Global Vs Spain Growth Comparison
Figure 79: Spain Market Share Analysis (%) By Product, 2021 to 2032
Figure 80: Spain Market Share Analysis (%) by Indication, 2021 to 2032
Figure 81: Russia Market Value Proportion Analysis, 2021
Figure 82: Global Vs Russia Growth Comparison
Figure 83: Russia Market Share Analysis (%) By Product, 2021 to 2032
Figure 84: Russia Market Share Analysis (%) by Indication, 2021 to 2032
Figure 85: BENELUX Market Value Proportion Analysis, 2021
Figure 86: Global Vs BENELUX Growth Comparison
Figure 87: BENELUX Market Share Analysis (%) By Product, 2021 to 2032
Figure 88: BENELUX Market Share Analysis (%) by Indication, 2021 to 2032
Figure 89: East Asia Market Value (US$ million) Analysis, 2012 to 2021
Figure 90: East Asia Market Value (US$ million) Forecast, 2022 to 2032
Figure 91: East Asia Market Value Share, By Product (2022 E)
Figure 92: East Asia Market Value Share, by Indication (2022 E)
Figure 93: East Asia Market Value Share, by Country (2022 E)
Figure 94: East Asia Market Attractiveness Analysis By Product, 2022 to 2032
Figure 95: East Asia Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 96: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 97: China Market Value Proportion Analysis, 2021
Figure 98: Global Vs. China Growth Comparison
Figure 99: China Market Share Analysis (%) By Product, 2021 to 2032
Figure 100: China Market Share Analysis (%) by Indication, 2021 to 2032
Figure 101: Japan Market Value Proportion Analysis, 2021
Figure 102: Global Vs. Japan Growth Comparison
Figure 103: Japan Market Share Analysis (%) By Product, 2021 to 2032
Figure 104: Japan Market Share Analysis (%) by Indication, 2021 to 2032
Figure 105: South Korea Market Value Proportion Analysis, 2021
Figure 106: Global Vs South Korea Growth Comparison
Figure 107: South Korea Market Share Analysis (%) By Product, 2021 to 2032
Figure 108: South Korea Market Share Analysis (%) by Indication, 2021 to 2032
Figure 109: South Asia Market Value (US$ million) Analysis, 2012 to 2021
Figure 110: South Asia Market Value (US$ million) Forecast, 2022 to 2032
Figure 111: South Asia Market Value Share, By Product (2022 E)
Figure 112: South Asia Market Value Share, by Indication (2022 E)
Figure 113: South Asia Market Value Share, by Country (2022 E)
Figure 114: South Asia Market Attractiveness Analysis By Product, 2022 to 2032
Figure 115: South Asia Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 116: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 117: India Market Value Proportion Analysis, 2021
Figure 118: Global Vs. India Growth Comparison
Figure 119: India Market Share Analysis (%) By Product, 2021 to 2032
Figure 120: India Market Share Analysis (%) by Indication, 2021 to 2032
Figure 121: Indonesia Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Indonesia Growth Comparison
Figure 123: Indonesia Market Share Analysis (%) By Product, 2021 to 2032
Figure 124: Indonesia Market Share Analysis (%) by Indication, 2021 to 2032
Figure 125: Malaysia Market Value Proportion Analysis, 2021
Figure 126: Global Vs. Malaysia Growth Comparison
Figure 127: Malaysia Market Share Analysis (%) By Product, 2021 to 2032
Figure 128: Malaysia Market Share Analysis (%) by Indication, 2021 to 2032
Figure 129: Thailand Market Value Proportion Analysis, 2021
Figure 130: Global Vs. Thailand Growth Comparison
Figure 131: Thailand Market Share Analysis (%) By Product, 2021 to 2032
Figure 132: Thailand Market Share Analysis (%) by Indication, 2021 to 2032
Figure 133: Oceania Market Value (US$ million) Analysis, 2012 to 2021
Figure 134: Oceania Market Value (US$ million) Forecast, 2022 to 2032
Figure 135: Oceania Market Value Share, By Product (2022 E)
Figure 136: Oceania Market Value Share, by Indication (2022 E)
Figure 137: Oceania Market Value Share, by Country (2022 E)
Figure 138: Oceania Market Attractiveness Analysis By Product, 2022 to 2032
Figure 139: Oceania Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 140: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 141: Australia Market Value Proportion Analysis, 2021
Figure 142: Global Vs. Australia Growth Comparison
Figure 143: Australia Market Share Analysis (%) By Product, 2021 to 2032
Figure 144: Australia Market Share Analysis (%) by Indication, 2021 to 2032
Figure 145: New Zealand Market Value Proportion Analysis, 2021
Figure 146: Global Vs New Zealand Growth Comparison
Figure 147: New Zealand Market Share Analysis (%) By Product, 2021 to 2032
Figure 148: New Zealand Market Share Analysis (%) by Indication, 2021 to 2032
Figure 149: Middle East & Africa Market Value (US$ million) Analysis, 2012 to 2021
Figure 150: Middle East & Africa Market Value (US$ million) Forecast, 2022 to 2032
Figure 151: Middle East & Africa Market Value Share, By Product (2022 E)
Figure 152: Middle East & Africa Market Value Share, by Indication (2022 E)
Figure 153: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 154: Middle East & Africa Market Attractiveness Analysis By Product, 2022 to 2032
Figure 155: Middle East & Africa Market Attractiveness Analysis by Indication, 2022 to 2032
Figure 156: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 157: GCC Countries Market Value Proportion Analysis, 2021
Figure 158: Global Vs GCC Countries Growth Comparison
Figure 159: GCC Countries Market Share Analysis (%) By Product, 2021 to 2032
Figure 160: GCC Countries Market Share Analysis (%) by Indication, 2021 to 2032
Figure 161: Turkey Market Value Proportion Analysis, 2021
Figure 162: Global Vs. Turkey Growth Comparison
Figure 163: Turkey Market Share Analysis (%) By Product, 2021 to 2032
Figure 164: Turkey Market Share Analysis (%) by Indication, 2021 to 2032
Figure 165: South Africa Market Value Proportion Analysis, 2021
Figure 166: Global Vs. South Africa Growth Comparison
Figure 167: South Africa Market Share Analysis (%) By Product, 2021 to 2032
Figure 168: South Africa Market Share Analysis (%) by Indication, 2021 to 2032
Figure 169: North Africa Market Value Proportion Analysis, 2021
Figure 170: Global Vs North Africa Growth Comparison
Figure 171: North Africa Market Share Analysis (%) By Product, 2021 to 2032
Figure 172: North Africa Market Share Analysis (%) by Indication, 2021 to 2032
The global market for scleral lenses is estimated to be worth USD 175.5 million in 2022.
The scleral lenses market is expected to reach USD 323.5 million by end of 2032 at a CAGR of 6.3%.
Growing awareness regarding scleral lenses, a rising number of eye disorders, and expanded distribution networks of manufacturing companies, are some of the key trends in this market.
North America dominated the global market accounting for the highest market share of 42.9% in 2021, while growing at a CAGR of close to 5.6%
The United Kingdom market contributes around USD 14.9 million in 2021 in the Europe market.
India accounts for about 59.8% of the market share of the South Asian market in 2021.
The USA, Germany, The United Kingdom, India, and Australia are the top five countries, which are expected to drive demand in the global market.
From 2012 to 2021, the market for scleral lenses expanded at a CAGR of 3.0%.
Australia accounted for 78.0% market share of the Oceania market in 2021.
Germany held a market share of around 44.7% of the Europe market in 2021.
Explore Therapeutic Device Insights
Scleral Lenses Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
